Abstract
The following undermentioned case report shows a frequent overlaping of symptoms and findings in a non frequent disease – lymphangioleiomyomatose (LAM). In discussion of the case you can find not only symptoms and therapy in our female patient, but also molecular principles of this disease in a relationship to new perspectives and potentials in the treatment.
Currently, it is obvious, unfortunately, that the most of patients with LAM have to undergo lung transplantation (LTX).